Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Smartwatch and ring data could help AI predict Post-Surgery hospital readmissions

NCT ID NCT07349901

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether artificial intelligence can predict hospital readmissions in surgical patients by analyzing data from smartwatches and smart rings. About 300 adults undergoing elective surgery will wear these devices before and after their operation, tracking heart rate, sleep, and other health signals. The goal is to see if AI can catch early warning signs of complications that doctors might miss, potentially leading to safer recoveries.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could give doctors a new tool to spot early signs of trouble after surgery, potentially reducing complications and readmissions.
What could go wrong
This is an early-stage observational study, not a treatment trial. The AI models may not prove accurate enough for real-world use, and results may not apply to other hospitals or patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will consist of adult patients scheduled for medium- and large-scale elective surgeries at the Hospital Universitário Getúlio Vargas, a tertiary referral center in Amazonas. Patients are initially evaluated at the affiliated outpatient clinic, Ambulatório Araújo Lima. Eligible individuals will be invited to participate during preoperative consultations with the attending surgeon, approximately 15 days before hospital admission. Study procedures, information delivery, and informed consent will be conducted by the surgical specialists responsible for outpatient care.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults over 18 years of age; * Hospitalization for medium and/or large elective surgery at HUGV; * Conscious and oriented patients who have sufficient understanding to answer questionnaires and use wearable devices for the study; * Have minimal skills in the use of wearable technologies; * Patients who have agreed to participate voluntarily in the research by signing the Informed Consent Form (ICF). Non-inclusion Criteria: * Presence of tattoos or any other skin condition (skin pathologies or skin diseases such as vitiligo, lupus, and atopic dermatitis, among others) that affects the area of the wrist or finger where the wearable sensors are located; * Presence of any type of sensitivity or allergic reaction, of any degree, to the materials of the wearables (smartwatch and smartring); * Pregnant and lactating women; * Participants with implantable cardiac devices, such as pacemakers, cardioverter defibrillators, and resynchronization devices; * Participants in drugs abuse; Exclusion Criteria: * Severe medical conditions and decompensations prior to surgery; * Patients who die before hospital discharge; * Patients with an expected postoperative hospital stay of more than 10 days.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Patient readmission are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Postoperative Complications sleep-wake disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Getúlio Vargas University Hospital

    RECRUITING

    Manaus, Amazonas, 69020-170, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.